American Heart Journal
Volume 149, Issue 5 , Pages 785-794 , May 2005

Barriers to hypertension control

  • Ann M. Borzecki, MD, MPH

      Affiliations

    • Center for Health Quality, Outcomes, and Economic Research, Bedford Veterans Affairs Hospital, Bedford, Mass
    • Department of Health Services, Boston University School of Public Health, Boston, Mass
    • Corresponding Author InformationReprints not available from authors.
    • ,
  • Susan A. Oliveria, ScD, MPH

      Affiliations

    • The Epigroup, Galt Associates, Inc, Sterling, Va
    • Department of Public Health, Weill Medical College of Cornell University, New York, NY
    • Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY
    • ,
  • Dan R. Berlowitz, MD, MPH

      Affiliations

    • Center for Health Quality, Outcomes, and Economic Research, Bedford Veterans Affairs Hospital, Bedford, Mass
    • Department of Health Services, Boston University School of Public Health, Boston, Mass

Received 25 January 2005 ,Accepted 25 January 2005.

References 

  1. The Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure . The 1988 Report of the Joint National Committee on Detection, evaluation and treatment of high blood pressure. Arch Intern Med. 1988;148:1023–1038
  2. National Institutes of Health, National Heart, Lung and Blood Institute . Diagnosis and management of hypertension—1987. A nationwide survey of physicians' knowledge, attitudes and reported behavior. Washington (DC): United States Department of Health and Human Services, Public Health Service; 1989;[publication no. 89-2968]
  3. Berlowitz DR, Ash AS, Hickey EC. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957–1962
  4. Oliveria SA, Lapuerta P, McCarthy BD. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413–420
  5. Moy E, Bartman BA, Weir MR. Access to hypertensive care. Effects of income, insurance, and source of care. Arch Intern Med. 1995;155:1497–1502
  6. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure . The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413–2446
  7. Bosworth HB, Oddone EZ. A model of psychosocial and cultural antecedents of blood pressure control. J Natl Med Assoc. 2002;94:236–248
  8. NHLBI Working Group. Management of patient compliance in the treatment of hypertension. Hypertension. 1982;4:415–423
  9. Wang PS, Bohn RL, Knight E. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002;17:504–511
  10. Christensen DB, Williams B, Goldberg HI. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care. 1997;35:1164–1170
  11. Ren XS, Kazis LE, Lee A. Identifying patient and physician characteristics that affect compliance with antihypertensive medications. J Clin Pharm Ther. 2002;27:47–56
  12. Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther. 1998;20:671–681
  13. Stephenson DJ, Rowe BH, Haynes RB. The rational clinical examination. Is this patient taking the treatment as prescribed?. JAMA. 1993;269:2779–2781
  14. Steiner JF, Koepsell TD, Fihn SD. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care. 1988;26:814–823
  15. Morisky DE, Ward HJ. Self-reported medication-taking behavior: a valid method for assessing adherence. [abstract] Am J Hypertens. 2001;14:231A
  16. Stephenson J. Noncompliance may cause half of antihypertensive drug “failures”. JAMA. 1999;282:313–314
  17. Alderman EL, Coltart DJ, Wettach GE. Coronary artery syndromes after sudden propranolol withdrawal. Ann Intern Med. 1974;81:625–627
  18. Miller RR, Olson HG, Amsterdam EA. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med. 1975;293:416–418
  19. McAlister FA, O'Connor AM, Wells G. When should hypertension be treated? The different perspectives of Canadian family physicians and patients. CMAJ. 2000;163:403–408
  20. Gallup G, Cotugno HE. Preferences and practices of Americans and their physicians in antihypertensive therapy. Am J Med. 1986;81:20–24
  21. Miller NH, Hill M, Kottke T. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 1997;95:1085–1090
  22. Eisen SA, Miller DK, Woodward RS. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881–1884
  23. Leenen FH, Wilson TW, Bolli P. Patterns of compliance with once versus twice daily antihypertensive therapy in primary care: a randomized clinical trial using electronic monitoring. Can J Cardiol. 1997;13:914–920
  24. Baird MG, Bentley-Taylor MM, Carruthers SG. A study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension. Betaloc Compliance Cooperative Study Group. Clin Invest Med. 1984;7:95–102
  25. Girvin B, McDermott BJ, Johnston GD. A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance. J Hypertens. 1999;17:1627–1631
  26. Hilleman DE, Mohiuddin SM, Lucas BD. Conversion from sustained-release to immediate-release calcium entry blockers: Outcome in patients with mild-to-moderate hypertension. Clin Ther. 1993;15:1002–1010
  27. Caro JJ, Salas M, Speckman JL. Persistence with treatment for hypertension in actual practice. CMAJ. 1999;160:31–37
  28. Monane M, Bohn RL, Gurwitz JH. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens. 1997;10:697–704
  29. Fincke BG, Miller DR, Spiro A. The interaction of patient perception of overmedication with drug compliance and side effects. J Gen Intern Med. 1998;13:182–185
  30. Nelson EC, Stason WB, Neutra RR. Identification of the noncompliant hypertensive patient. Prev Med. 1980;9:504–517
  31. Caro JJ, Speckman JL, Salas M. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ. 1999;160:41–46
  32. Wannemacher AJ, Schepers GP, Townsend KA. Antihypertensive medication compliance in a Veterans Affairs Healthcare System. Ann Pharmacother. 2002;36:986–991
  33. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–2997
  34. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703–713
  35. Flack JM, Novikov SV, Ferrario CM. Benefits of adherence to anti-hypertensive drug therapy. Eur Heart J. 1996;17(Suppl A):16–20
  36. Burt V, Whelton P, Roccella EJ. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995;25:305–313
  37. Spiro A, Aldwin CM, Ward KD. Personality and the incidence of hypertension among older men: Longitudinal findings from the Normative Aging Study. Health Psychol. 1995;14:563–569
  38. Smyth KA, Yarandi HN. Relative risk of untreated hypertension in type-A employed African American women. J Hum Hypertens. 1994;8:89–93
  39. Vaillant GE, Gerber PD. Natural history of male psychological health, XIII: who develops high blood pressure and who responds to treatment. Am J Psychiatry. 1996;153(7 Suppl):24–29
  40. Friedman R, Schwartz JE, Schnall PL. Psychological variables in hypertension: relationship to casual or ambulatory blood pressure in men. Psychosom Med. 2001;63:19–31
  41. Suter PM, Maire R, Holtz D. Relationship between self-perceived stress and blood pressure. J Hum Hypertens. 1997;11:171–176
  42. House JS, Landis KR, Umberson D. Social relationships and health. Science. 1988;241:540–545
  43. Barefoot JC, Helms MJ, Mark DB. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol. 1996;78:613–617
  44. Williams RB, Barefoot JC, Califf RM. Prognostic importance of social and economic resources among medically treated patients with angiographically documented coronary artery disease. JAMA. 1992;267:520–524
  45. Berkman LF, Leo-Summers L, Horwitz RI. Emotional support and survival after myocardial infarction. A prospective, population-based study of the elderly. Ann Intern Med. 1992;117:1003–1009
  46. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160:2281–2286
  47. Hajjar I, Miller K, Hirth V. Age-related bias in the management of hypertension: a national survey of physicians' opinions on hypertension in elderly adults. J Gerontol A Biol Sci Med Sci. 2002;57:M487–M491
  48. Asai Y, Heller R, Kajii E. Hypertension control and medication increase in primary care. J Hum Hypertens. 2002;16:313–318
  49. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479–486
  50. Phillips LS, Branch WT, Cook CB. Clinical inertia. Ann Intern Med. 2001;135:825–834
  51. Institute of Medicine . Access to health care in America: a model for monitoring access. Washington (DC): National Academy Press; 1993;
  52. Cooper LA, Hill MN, Powe NR. Designing and evaluating interventions to eliminate racial and ethnic disparities in health care. J Gen Intern Med. 2002;17:477–486
  53. Ahluwalia JS, McNagny SE, Rask KJ. Correlates of controlled hypertension in indigent, inner-city hypertensive patients. J Gen Intern Med. 1997;12:7–14
  54. Shea S, Misra D, Ehrlich MH. Predisposing factors for severe, uncontrolled hypertension in an inner-city minority population. N Engl J Med. 1992;327:776–781
  55. Keeler EB, Brook RH, Goldberg GA. How free care reduced hypertension in the health insurance experiment. JAMA. 1985;254:1926–1931
  56. Coleman MT, Lott JA, Sharma S. Use of continuous quality improvement to identify barriers in the management of hypertension. Am J Med Qual. 2000;15:72–77
  57. Mouton CP, Beaudouin R, Troutman A. Barriers to follow-up of hypertensive patients. J Health Care Poor Underserved. 2001;12:290–301
  58. O'Malley AS, Forrest CB, Mandelblatt J. Adherence of low-income women to cancer screening recommendations. J Gen Intern Med. 2002;17:144–154
  59. Cooper-Patrick L, Gallo JJ, Gonzales JJ. Race, gender, and partnership in the patient-physician relationship. JAMA. 1999;282:583–589
  60. Kaplan SH, Greenfield S, Ware JE. Assessing the effects of physician-patient interactions on the outcomes of chronic disease. Med Care. 1989;27(3 Suppl):S110–S127
  61. Hall JA, Roter DL, Katz NR. Meta-analysis of correlates of provider behavior in medical encounters. Med Care. 1988;26:657–675
  62. Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ. 1995;152:1423–1433
  63. Orth JE, Stiles WB, Scherwitz L. Patient exposition and provider explanation in routine interviews and hypertensive patients' blood pressure control. Health Psychol. 1987;6:29–42
  64. Cabana MD, Rand CS, Powe NR. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458–1465
  65. McAlister FA, Campbell NR, Zarnke K. The management of hypertension in Canada: A review of current guidelines, their shortcomings and implications for the future. CMAJ. 2001;164:517–522
  66. Cranney M, Warren E, Barton S. Why do GPs not implement evidence-based guidelines? A descriptive study. Fam Pract. 2001;18:359–363
  67. Kotchen JM, McKean HE, Jackson-Thayer S. Impact of a rural high blood pressure control program on hypertension control and cardiovascular disease mortality. JAMA. 1986;255:2177–2182
  68. Krishan I, Brennan LA, Nobrega FT. The Mayo three community hypertension control program. II. Outcome of intervention in entire communities. Mayo Clin Proc. 1979;54:299–306
  69. Greco PJ, Eisenberg JM. Changing physicians' practices. N Engl J Med. 1993;329:1271–1273
  70. Inui TS, Yourtee EL, Williamson JW. Improved outcomes in hypertension after physician tutorials. A controlled trial. Ann Intern Med. 1976;84:646–651
  71. Dickinson JC, Warshaw GA, Gehlbach SH. Improving hypertension control: impact of computer feedback and physician education. Med Care. 1981;19:843–854
  72. Putnam RW, Curry L. Physicians' participation in establishing criteria for hypertension management in the office: will patient outcomes be improved?. CMAJ. 1989;140:806–809
  73. Evans CE, Haynes RB, Birkett NJ. Does a mailed continuing education program improve physician performance? Results of a randomized trial in antihypertensive care. JAMA. 1986;255:501–504
  74. Gullion DS, Tschann JM, Adamson TE. Management of hypertension in private practice: a randomised controlled trail in continuing medical education. J Contin Educ. 1988;8:239–255
  75. Jennett PA, Wilson TW, Hayton RC. Desirable behaviours in the office management of hypertension addressed through continuing medical education. Can J Public Health. 1989;80:359–362
  76. Bulpitt CJ, Beilin LJ, Coles EC. Randomised controlled trial of computer-held medical records in hypertensive patients. BMJ. 1976;1:677–679
  77. Coe FL, Norton E, Oparil S. Treatment of hypertension by computer and physician—a prospective controlled study. J Chronic Dis. 1977;30:81–92
  78. Barnett GO, Winickoff RN, Morgan MM. A computer-based monitoring system for follow-up of elevated blood pressure. Med Care. 1983;21:400–409
  79. McAlister NH, Covvey HD, Tong C. Randomized controlled trial of computer assisted management of hypertension in primary care. BMJ. 1986;293:670–674
  80. McDowell I, Newell C, Rosser W. A randomized trial of computerized reminders for blood pressure screening in primary care. Med Care. 1989;27:297–305
  81. Montgomery AA, Fahey T, Peters TJ. Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trail. BMJ. 2000;320:686–690
  82. Rossi RA, Every NR. A computerized intervention to decrease the use of calcium channel blockers in hypertension. J Gen Intern Med. 1997;12:672–678
  83. Rogers JL, Haring OM, Wortman PL. Medical information systems: assessing impact in the areas of hypertension, obesity and renal disease. Med Care. 1982;20:63–74
  84. Hetlevik I, Holmen J, Kruger O. Implementing clinical guidelines in the treatment of hypertension in general practice. Evaluation of patient outcome related to implementation of a computer-based clinical decision support system. Scand J Prim Health Care. 1999;17:35–40
  85. Winickoff RN, Wilner S, Neisular R. Limitations of provider interventions in hypertension quality assurance. Am J Public Health. 1985;75:43–46
  86. Soumerai SB, McLaughlin TJ, Gurwitz JH. Effect of local medical opinion leaders on quality of care for acute myocardial infarction: A randomized controlled trial. JAMA. 1998;279:1358–1363
  87. Goldberg HI, Wagner EH, Fihn SD. A randomized controlled trial of CQI teams and academic detailing: can they alter compliance with guidelines?. Joint Comm J Qual Improv. 1998;24:130–142
  88. Mashru M, Lant A. Interpractice audit of diagnosis and management of hypertension in primary care: Educational intervention and review of medical records. BMJ. 1997;314:942–946
  89. Grimshaw JM, Shirran L, Thomas R. Changing provider behavior: An overview of systematic reviews of interventions. Med Care. 2001;39(8 Suppl 2):II2–II45
  90. Gonzalez-Fernandez RA, Rivera M, Torres D. Usefulness of a systemic hypertension in-hospital educational program. Am J Cardiol. 1990;65:1384–1386
  91. Roca-Cusachs A, Sort D, Atlimira J. The impact of a patient education programme in the control of hypertension. J Hum Hypertens. 1991;5:437–441
  92. Watkins CJ, Papacosta AO, Chinn S. A randomized controlled trial of an information booklet for hypertensive patients in general practice. J R Coll Gen Pract. 1987;37:548–550
  93. Becker LA, Glanz K, Sobel E. A randomized trial of special packaging of antihypertensive medications. J Fam Pract. 1986;22:357–361
  94. McKenney JM, Munroe WP, Wright JT. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol. 1992;32:277–283
  95. Haynes RB, Sackett DL, Gibson ES. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976;1:1265–1268
  96. Johnson AL, Taylor DW, Sackett DL. Self-recording of blood pressure in the management of hypertension. CMAJ. 1978;119:1034–1039
  97. Nessman DG, Carnahan JE, Nugent CA. Increasing compliance. Patient-operated hypertension groups. Arch Intern Med. 1980;140:1427–1430
  98. Friedman RH, Kazis LE, Jette A. A telecommunication system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9:285–292
  99. Rogers MA, Small D, Buchan DA. Home monitoring service improves mean arterial pressure in patients with essential hypertension. A randomized, controlled trial. Ann Intern Med. 2001;134:1024–1032
  100. Artinian NT, Washington OG, Templin TN. Effects of home monitoring and community-based monitoring on blood pressure control in urban African Americans: a pilot study. Heart Lung. 2001;30:191–199
  101. Morisky DE, DeMuth NM, Field-Fass M. Evaluation of family health education to build social support for long-term control of high blood pressure. Health Educ Q. 1985;12:35–50
  102. Haynes RB, McDonald H, Garg AX. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev. 2002;2:CD000011
  103. Ebrahim S. Detection, adherence and control of hypertension for the prevention of stroke: a systematic review. Health Technol Assess 1998;2:i-iv,1-78.
  104. Bodenheimer T. Disease management—promises and pitfalls. N Engl J Med. 1999;340:1202–1205
  105. Perry HM, Schnaper HW, Meyer G. Clinical program for screening and treatment of hypertension in veterans. J Natl Med Assoc. 1982;74:433–444
  106. Statson WB, Shepard DS, Perry HM. Effectiveness and costs of Veterans Affairs hypertension clinics. Med Care. 1994;32:1197–1215
  107. Logan AG, Milne BJ, Achber C. Work-site treatment of hypertension by specially trained nurses. A controlled trial. Lancet. 1979;2:1175–1178
  108. Logan AG, Milne BJ, Flanagan PT. Clinical effectiveness and cost-effectiveness of monitoring blood pressure of hypertensive employees at work. Hypertension. 1983;5:828–836
  109. Bogden PE, Abbott RD, Williamson P. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med. 1998;13:740–745

PII: S0002-8703(05)00118-3

doi: 10.1016/j.ahj.2005.01.047

American Heart Journal
Volume 149, Issue 5 , Pages 785-794 , May 2005

Article Tools

* Image Usage & Resolution